Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture

Cardiovascular Research

Volumn 41, Issue 2, 1999, Pages 361-368

  Bennett, Martin R ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Atherosclerosis; Human; Vascular smooth muscle

Indexed keywords

CYTOKINE;

ANGIOPLASTY; APOPTOSIS; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY THROMBOSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; RESTENOSIS; REVIEW; SMOOTH MUSCLE FIBER; TUMOR SUPPRESSOR GENE; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; ARTERIES; ARTERIOSCLEROSIS; EXTRACELLULAR MATRIX; HUMANS; LIPOPROTEINS, LDL; METALLOENDOPEPTIDASES; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0033053063     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00212-0     Document Type: Review

References (99)

1. Mintz G.S., Popma J.J., Pichard A.D.et al. Intravascular ultrasound assessment of the mechanisms and predictors of restenosis following coronary angioplasty. J Invest Cardiol. 9:1997;303-314.
2. Glagov S., Weisenberg E., Zarins C.K., Stankunavicius R., Kolettis G.J. Compensatory enlargement of human atherosclerotic coronary arteries. New Engl J Med. 316:1987;1371-1375.
3. Clarkson T.B., Prichard R.W., Morgan T.M., Petrick G.S., Klein K.P. Remodeling of coronary arteries in human and nonhuman primates. J Am Med Assoc. 271:1994;289-294.
4. Post M.J., Borst C., Kuntz R.E. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation. 89:1994;2816-2821.
5. Andersen H.R., Maeng M., Thorwest M., Falk E. Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury-Insights from a porcine coronary (re)stenosis model. Circulation. 93:1996;1716-1724.
6. Wilensky R., March K., Graduspizlo I., Sandusky G., Fineberg N., Hathaway D. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. Circulation. 92(10):1995;2995-3005.
7. Kakuta T., Currier J.W., Haudenschild C.C., Ryan T.J., Faxon D.P. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation. 89:1994;2809-2815.
8. Lafont A., Guzman L., Whitlow P.et al. Restenosis after experimental angioplasty-intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res. 76:1995;996-1002.
9. Geary R.L., Williams J.K., Golden D.et al. Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis. A nonhuman primate model of restenosis. Arterioscler Thromb Vasc Biol. 16:1996;34-43.
10. Waller B.F., Pinkerton C.A., Orr C.M.et al. Restenosis 1 to 24 months after clinically successful coronary balloon angioplasty: a necropsy study of 20 patients. J Am Coll Cardiol. 17(Suppl B):1991;58B-70B.
11. Mintz G., Popma J., Pichard A.et al. Arterial remodeling after coronary angioplasty. A serial intravascular ultrasound study. Circulation. 94:1996;35-43.
12. Scott N.A., Cipolla G.D., Ross C.E.et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation. 93:1996;2178-2187.
13. Shi Y., Pieniek M., Fard A.et al. Adventitial remodeling after coronary arterial injury. Circulation. 93:1996;340-348.
14. Shi Y., O'Brien J., Ala-Kokko L.et al. Origin of extracellular matrix synthesis during coronary repair (Abstract). Circulation. 95:1997;1997.
15. Riessen R., Isner J.M., Blessing E.et al. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol. 144:1994;962-974.
16. Tyagi S.C., Meyer L., Schmaltz R.A., Reddy H.K., Voelker D.J. Proteinases and restenosis in the human coronary artery: extracellular matrix production exceeds the expression of proteolytic activity. Atherosclerosis. 116:1995;43-57.
17. Cho A., Courtman D., Langille L. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res. 76:1995;168-175.
18. Cho A., Mitchell L., Koopmans D., Langille B.L. Effects of changes in blood flow rate on cell death and cell proliferation in carotid arteries of immature rabbits. Circ Res. 81:1997;328-337.
19. Kumar A., Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol. 17:1997;2238-2244.
20. Slomp J., GittenbergerdeGroot A.C., Glukhova M.A.et al. Differentiation, dedifferentiation, and apoptosis of smooth muscle cells during the development of the human ductus arteriosus. Arterioscler Thromb Vasc Biol. 17:1997;1003-1009.
21. deBlois D., Tea B.S., Dam T.V., Tremblay J., Hamet P. Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension. 29:1997;340-349.
22. Perlman H., Maillard L., Krasinski K., Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation. 95:1997;981-987.
23. Pollman M.J., Hall J.L., Mann M.J.et al. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nature Med. 4:1998;222-227.
24. Bochatonpiallat M., Gabbiani F., Redard M., Desmouliere A., Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol. 146:1995;1059-1064.
25. Han D., Haudenschild C., Hong M. Evidence for apoptosis in human atherosclerosis and in a rat vascular injury model. Am J Pathol. 147:1995;267-277.
26. Clowes A.W., Reidy M.A., Clowes M.M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest. 49:1983;327-333.
27. Isner J., Kearney M., Bortman S., Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 91:1995;2703-2711.
28. Yonehara S., Ishii A., Yonehara M. A cell killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med. 169:1989;1747-1756.
29. Itoh N., Yonehara S., Ishii A.et al. The polypeptide encoded by the human cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:1991;233-243.
30. Zou H., Henzel W.J., Liu X.S.et al. Apaf-1, a human protein homologous to C-elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 90:1997;405-413.
31. Krajewska M., Wang H.G., Krajewski S.et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Res. 57:1997;1605-1613.
32. Schonbeck U., Herzberg M., Petersen A.et al. Human vascular smooth muscle cells express interleukin-1 beta-converting enzyme (ICE), but inhibit processing of the interleukin-1 beta precursor by ICE. J Exp Med. 185:1997;1287-1294.
33. Langille B.L., O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science. 231:1986;405-407.
34. Ankarcrona M., Dypbukt J.M., Brune B., Nicotera P. Interleukin-1 beta-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res. 213:1994;172-177.
35. Geng Y., Wu Q., Muszynski M., Hansson G., Libby P. Apoptosis of vascular smooth-muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1-beta. Arterioscler Thromb Vasc Biol. 16:1996;19-27.
36. Fukuo K., Hata S., Suhara T.et al. Nitric oxide induces up regulation of fas and apoptosis in vascular smooth muscle. Hypertension. 27:1996;823-826.
37. Geng Y., Hellstrand K., Wennmalm A., Hansson G. Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to gamma interferon and tumor necrosis factor alpha. Cancer Res. 56:1996;866-874.
38. Pollman M., Yamada T., Horiuchi M., Gibbons G. Vasoactive substances regulate vascular smooth muscle cell apoptosis-countervailing influences of nitric oxide and angiotensin II. Circ Res. 79:1996;748-756.
39. Sandau K., Pfeilschifter J., Brune B. Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. Kidney Int. 52:1997;378-386.
40. LopezCollazo E., Mateo J., MirasPortugal M.T., Bosca L. Requirement of nitric oxide and calcium mobilization for the induction of apoptosis in adrenal vascular endothelial cells. FEBS Lett. 413:1997;124-128.
41. O'Connor M., Salzman A.L., Szabo C. Role of peroxynitrite in the protein oxidation and apoptotic DNA fragmentation in vascular smooth muscle cells stimulated with bacterial lipopolysaccharide and interferon-gamma. Shock. 8:1997;439-443.
42. Messmer U.K., Ankarcrona M., Nicotera P., Brune B. p53 expression in nitric oxide-induced apoptosis. FEBS Lett. 355:1994;23-26.
43. Zhao Z.H., Francis C.E., Welch G., Loscalzo J., Ravid K. Reduced glutathione prevents nitric oxide-induced apoptosis in vascular smooth muscle cells. Biochim Biophys Acta. 1359:1997;143-152.
44. Fukuo K., Nakahashi T., Nomura S.et al. Possible participation of Fas-mediated apoptosis in the mechanism of atherosclerosis. Gerontology. 43:1997;35-42.
45. Geng Y.J., Henderson L.E., Levesque E.B., Muszynski M., Libby P. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 17:1997;2200-2208.
46. Xie K.P., Wang Y.F., Huang S.Y.et al. Nitric oxide-mediated apoptosis of K-1735 melanoma cells is associated with downregulation of Bcl-2. Oncogene. 15:1997;771-779.
47. Hata S., Fukuo K., Nakahashi T.et al. Vascular endothelial growth factor prevents nitric oxide-induced down-regulation of bcl-2 and apoptosis in endothelial-cells (Abstract). Hypertension. 28:1996;66.
48. Dimmeler S., Haendeler J., Rippmann V., Nehls M., Zeiher A.M. Shear stress inhibits apoptosis of human endothelial cells. FEBS Lett. 399:1996;71-74.
49. Dimmeler S., Haendeler J., Nehls M., Zeiher A.M. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med. 185:1997;601-607.
50. Li J.R., Billiar T.R., Talanian R.V., Kim Y.M. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun. 240:1997;419-424.
51. Ogura T., Tatemichi M., Esumi H. Nitric oxide inhibits CPP32-like activity under redox regulation. Biochem Biophys Res Commun. 236:1997;365-369.
52. Mannick J.B., Miao X.Q., Stamler J.S. Nitric oxide inhibits Fas-induced apoptosis. J Biol Chem. 272:1997;24125-24128.
53. Calmels S., Hainaut P., Ohshima H. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res. 57:1997;3365-3369.
54. Pollman M., Hall J., Gibbons G. Acute induction of medial cell apoptosis by angioplasty injury: Regulation by redox-sensitive mechanisms (Abstract). Circulation. 96:1997;I-560.
55. Sata M., Perlman H.R., Muruve D.A.et al. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc Natl Acad Sci USA. 95:1998;1213-1217.
56. Davies M.J., Richardson P.D., Woolf N., Katz D.R., Mann J. Risk of thrombosis in human atherosclerotic plaques-role of extracellular lipid, macrophage, and smooth-muscle cell content. Br Heart J. 69:1993;377-381.
57. Geng Y., Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1b converting enzyme. Am J Pathol. 147:1995;251-266.
58. Bauriedel B., Schmucking I., Hutter R., Schmidt T. Increased apoptotic and necrotic cell death in human coronary plaques with unstable versus stable angina (Abstract). Circulation. 96:1997;I-290.
59. Gordon D., Reidy M.A., Benditt E.P., Schwartz S.M. Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA. 87:1990;4600-4604.
60. O'Brien E.R., Alpers C.E., Stewart D.K.et al. Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. Circ Res. 73:1993;223-231.
61. Kockx M., Muhring J., Bortier H., De Meyer G., Jacob W. Biotin or digoxygenin-conjugated nucleotides bind to matrix vesicles in atherosclerotic plaque. Am J Pathol. 148:1996;1771-1777.
62. Kockx M., Muhring J., Knaapen M., de Meyer G. RNA synthesis and splicing interferes with DNA in situ end labelling techniques used to detect apoptosis. Am J Pathol. 152:1998;885-888.
63. Bombeli T., Karsan A., Tait J.F., Harlan J.M. Apoptotic vascular endothelial cells become procoagulant. Blood. 89:1997;2429-2442.
64. Flynn P., Byrne C., Baglin T., Weissberg P.L., Bennett M.R. Thrombin generation by apoptotic vascular smooth muscle cells. Blood. 89:1997;4373-4384.
65. Bennett M.R., Gibson D., Schwartz S.M., Tait J.F. Binding and phagocytosis of apoptotic rat vascular smooth muscle cells is mediated in part by exposure to phosphatidylserine. Circ Res. 77:1995;1136-1142.
66. Han D.K.M., Wright M.E., Dixit V.M. Evidence for escape of apoptosis by loss of Fas in atherosclerotic plaque smooth muscle (Abstract). Circulation. 94:1996;2311-2311.
67. Tanaka H., Swanson S.J., Sukhova G., Schoen F.J., Libby P. Smooth-muscle cells of the coronary arterial tunica media express tumor-necrosis-factor-alpha and proliferate during acute rejection of rabbit cardiac allografts. Am J Pathol. 147:1995;617-626.
68. Bennett M.R., Evan G.I., Schwartz S.M. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 95:1995;2266-2274.
69. Bai H., Pollman M., Yang Z., Hall J., Gibbons G. Insulin-like growth factor inhibits vascular smooth muscle cell apoptosis by a signal transduction pathway involving phosphatidylinositol 3-kinase (Abstract). Circulation. 94:1996;I-156.
70. Fox J., Shanley J. Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells. J Biol Chem. 271:1996;12578-12584.
71. Neschis D.G., Safford S.D., Hanna A.K., Fox J.C., Golden M.A. Antisense basic fibroblast growth factor gene transfer reduces early intimal thickening in a rabbit femoral artery balloon injury model. J Vasc Surg. 27:1998;126-134.
72. Ross R., Masuda J., Raines E.W.et al. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science. 248:1990;1009-1012.
73. Poston R., Britten K., Nitkunan T.et al. Macrophage-associated growth factor and growth factor receptor expression in human atherosclerosis (Abstract). J Vasc Res. 33(S1):1996;79.
74. Kim H., Upadhyay S., Li G., Palmer K., Deuel T. Platelet-derived growth-factor induces apoptosis in growth-arrested murine fibroblasts. Proc Natl Acad Sci USA. 92(21):1995;9500-9504.
75. Ross R., Wight T.N., Strandness E., Thiele B. Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol. 114:1984;79-93.
76. Bennett M.R., Macdonald K., Chan S.W., Boyle J.J., Weissberg P.L. Co-operative interactions between RB and p53 regulate cell proliferation, cell senescence and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ Res. 82:1998;704-712.
77. Bennett M.R., Littlewood T.D., Schwartz S.M., Weissberg P.L. Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaque to p53-mediated apoptosis. Circ Res. 81:1997;591-599.
78. Iacopetta B., Wysocki S., Norman P., House A. The p53 tumour suppressor gene is overexpressed but not mutated in human atherosclerotic tissue. Int J Oncol. 7:1995;399-402.
79. Bennett M.R., Evan G.I., Schwartz S.M. Apoptosis of rat vascular smooth muscle cells is regulated by p53 dependent and independent pathways. Circ Res. 77:1995;266-273.
80. Yonemitsu Y., Kaneda Y., Tanaka S.et al. Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ Res. 82:1998;147-156.
81. Ihling C., Schaefer H., Dimmeler S., Zeiher A. Apoptosis in human atherosclerosis is associated with a dysregulated balance between Bcl-2 and Bax. Circulation. 96:1997;1-418.
82. Hayakawa Y., Takemura G., Ohno A.et al. Overexpression of Bax protein and mRNA, an inducer of apoptosis, in human arteriosclerosis. Circulation. 96:1997;I-177.
83. Montgomery A.M., Reisfeld R.A., Cheresh D.A. Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci USA. 91:1994;8856-8860.
84. Re F., Zanetti A., Sironi M.et al. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol. 127:1994;537-546.
85. Meredith J., Fazeli B., Schwartz M. The extracellular matrix as a cell survival factor. Mol Biol Cell. 4:1993;953-961.
86. McGill G., Shimamura A., Bates R.C., Savage R.E., Fisher D.E. Loss of matrix adhesion triggers rapid transformation-selective apoptosis in fibroblasts. J Cell Biol. 138:1997;901-911.
87. Kayagaki N., Kawasaki A., Ebata T.et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med. 182:1995;1777-1783.
88. Black R., Rauch C., Koziosky C.et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature. 385:1997;729-733.
89. Moss M., Jin S.-L.C., Milla M.et al. Cloning of a disintegrin metalloproteinase that processes precurser tumour-necrosis factor-α Nature. 385:1997;733-737.
90. Henney A.M., Wakeley P.R., Davies M.J.et al. Localization of stromolysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA. 88:1991;8154-8158.
91. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix-degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 94:1994;2493-2503.
92. Baker A.H., Zaltsman A., George S.J., Newby A.H. Divergent effects of tissue inhibitor of metalloproteinase-1, -2 or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation and death in vitro: TIMP-3 promotes apoptosis. J Clin Invest. 101:1998;1478-1487.
93. Björkerud B., Björkerud S. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages and fibroblasts. Arterioscler Thromb Vasc Biol. 16:1996;416-424.
94. Nishio E., Arimura S., Watanabe Y. Oxidized LDL induces apoptosis in cultured smooth muscle cells-a possible role for 7-ketocholesterol. Biochem Biophys Res Commun. 223:1996;413-418.
95. Diez J., Panizo A., Hernandez M., Pardo J. Is the regulation of apoptosis altered in smooth muscle cells of adult spontaneously hypertensive rats? Hypertension. 29:1997;776-780.
96. Jovinge S., Crisby M., Nilsson J. DNA fragmentation and ultrastructural changes of degenerating cells in atherosclerotic lesions and smooth muscle cells exposed to oxidised LDL in vitro. Arterioscler Thromb Vasc Biol. 17:1997;2225-2231.
97. Nishio E., Watanabe Y. Oxysterols induced apoptosis in cultured smooth-muscle cells through CPP32 protease activation and bcl-2 protein down-regulation. Biochem Biophys Res Commun. 226:1996;928-934.
98. Li P.F., Dietz R., vonHarsdorf R. Reactive oxygen species induce apoptosis of vascular smooth muscle cell. FEBS Lett. 404:1997;249-252.
99. Tsai J., Jain M., Hsieh C.et al. Induction of apoptosis by pyrrolidinedithiocarbamate and n-acetylcysteine in vascular smooth muscle cells. J Biol Chem. 271:1996;3667-3670.